Evaluation of the effect of melatonin in patients with COVID-19-induced pneumonia admitted to the Intensive Care Unit: A structured summary of a study protocol for a randomized controlled trial
중환자실에 입원한 COVID-19 유발 폐렴 환자에서 멜라토닌의 효과 평가: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
ABG
allergy
allocation sequence
anticipated
Arm
ARMS
arterial blood
arterial blood gas
Bandar Abbas
Blinding
block randomization
Blood
blood gas
Breastfeeding
C-reactive protein
C-RP
clinical
clinical symptom
Clinical symptoms
clinical trial
clinical trials
company
comparator
conducted
Control
control group
COVID-19
criteria
Definitive
definitive diagnosis
diagnosis of COVID-19
disease
Diseases
disorders
dissemination
dose
Effect
element
feature
ferritin
gelatin
generate
history
ICU
inclusion criteria
Inflammation
intensive care unit
intervention group
Iran
Laboratory
Lactate
lactate dehydrogenase
LDH
lung involvement
mechanical ventilation
melatonin
Ministry of Health
mortality rate
number
objective
Open-label
open-label trial
outcome
parallel-group
participant
Participants
Patient
patients
pharmaceutical
Pharmaceutical Company
Placebo
Pneumonia
Pregnancy
Primary outcome
Primary outcomes
protocol
random
randomization
randomize
Randomized
Randomized controlled trial
regimen
Registered
registration date
registration number
registry
renal
RT-PCR
Sample size
screened
secondary outcome
Secondary outcomes
Serological testing
Seven
severe pneumonia
severely ill patient
severely ill patients
single-center
standard treatment
status
Study protocol
supplementary material
therapeutic
Trial
trial protocol
Trial registration
twice a day
underlying diseases
Version
web-based system
website
[DOI] 10.1186/s13063-021-05162-3 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05162-3 PMC 바로가기 [Article Type] Letter